Xian-Yang Li

2.5k total citations
37 papers, 1.3k citations indexed

About

Xian-Yang Li is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Xian-Yang Li has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 18 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Xian-Yang Li's work include Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (9 papers) and interferon and immune responses (6 papers). Xian-Yang Li is often cited by papers focused on Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (9 papers) and interferon and immune responses (6 papers). Xian-Yang Li collaborates with scholars based in China, Australia and United States. Xian-Yang Li's co-authors include Mark J. Smyth, Achim K. Moesta, Jake S. O’Donnell, Jason Madore, Michele W.L. Teng, Jiang Zhu, Simon C. Robson, Nishamol Geetha, Amelia Roman Aguilera and Linjia Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Xian-Yang Li

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xian-Yang Li China 21 695 565 358 194 100 37 1.3k
Marika Karikoski Finland 17 491 0.7× 373 0.7× 422 1.2× 227 1.2× 72 0.7× 23 1.2k
Sally A. Hunsucker United States 17 236 0.3× 342 0.6× 588 1.6× 140 0.7× 72 0.7× 32 1.1k
Joel Crespo United States 7 863 1.2× 674 1.2× 396 1.1× 72 0.4× 183 1.8× 8 1.4k
Kevin Sek Australia 8 749 1.1× 935 1.7× 419 1.2× 179 0.9× 79 0.8× 11 1.3k
Swetha Anandhan United States 9 899 1.3× 951 1.7× 612 1.7× 58 0.3× 202 2.0× 13 1.8k
Xuhao Ni China 12 411 0.6× 273 0.5× 391 1.1× 76 0.4× 251 2.5× 16 967
Wenzhi Tian China 16 695 1.0× 431 0.8× 292 0.8× 28 0.1× 73 0.7× 53 1.1k
Jens Volkmer United States 8 862 1.2× 355 0.6× 381 1.1× 26 0.1× 79 0.8× 9 1.4k
Junyun Lai Australia 13 697 1.0× 819 1.4× 336 0.9× 38 0.2× 65 0.7× 16 1.2k
Malgorzata Czystowska United States 15 1.2k 1.7× 498 0.9× 890 2.5× 176 0.9× 559 5.6× 32 2.0k

Countries citing papers authored by Xian-Yang Li

Since Specialization
Citations

This map shows the geographic impact of Xian-Yang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xian-Yang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xian-Yang Li more than expected).

Fields of papers citing papers by Xian-Yang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xian-Yang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xian-Yang Li. The network helps show where Xian-Yang Li may publish in the future.

Co-authorship network of co-authors of Xian-Yang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xian-Yang Li. A scholar is included among the top collaborators of Xian-Yang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xian-Yang Li. Xian-Yang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yuyang, et al.. (2024). Mechanofluorochromic property of coumarin derivatives containing carbonyl group. Journal of Luminescence. 270. 120580–120580. 2 indexed citations
2.
Zhang, Yuchen, Xian-Yang Li, Huajing Wang, et al.. (2024). Development of a CD39 nanobody and its enhancement to chimeric antigen receptor T cells efficacy against ovarian cancer in preclinical studies. Theranostics. 14(16). 6249–6267. 7 indexed citations
3.
Hu, Jing, Eva Maria Putz, Simin Zheng, et al.. (2023). NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages. Proceedings of the National Academy of Sciences. 120(47). e2302126120–e2302126120. 17 indexed citations
4.
Liu, Yao, Jing Xiao, Jiacheng Bi, et al.. (2023). Review immune response of targeting CD39 in cancer. Biomarker Research. 11(1). 63–63. 29 indexed citations
5.
Luo, Xinran, Chenyu Huang, Yuting Zhang, et al.. (2023). The persistence and antitumor efficacy of CAR-T cells are modulated by tonic signaling within the CDR. International Immunopharmacology. 126. 111239–111239. 10 indexed citations
6.
Huang, Chen‐Yu, et al.. (2023). 326 Abstract withdrawn. SHILAP Revista de lepidopterología. A370–A372. 1 indexed citations
7.
Li, Xian-Yang, Dillon Corvino, Bianca Nowlan, et al.. (2022). NKG7 Is Required for Optimal Antitumor T-cell Immunity. Cancer Immunology Research. 10(2). 154–161. 32 indexed citations
8.
Zhan, Meixiao, Zhiren Zhang, Yuncong Zhang, et al.. (2022). CD155 in tumor progression and targeted therapy. Cancer Letters. 545. 215830–215830. 26 indexed citations
9.
Lu, Ligong, Meixiao Zhan, Xian-Yang Li, et al.. (2022). Clinically approved combination immunotherapy: Current status, limitations, and future perspective. SHILAP Revista de lepidopterología. 3. 118–127. 52 indexed citations
10.
Foley, Timothy L., Woodrow Burchett, Qiuxia Chen, et al.. (2021). Selecting Approaches for Hit Identification and Increasing Options by Building the Efficient Discovery of Actionable Chemical Matter from DNA-Encoded Libraries. SLAS DISCOVERY. 26(2). 263–280. 28 indexed citations
11.
Yan, Juming, Xian-Yang Li, Amelia Roman Aguilera, et al.. (2020). Control of Metastases via Myeloid CD39 and NK Cell Effector Function. Cancer Immunology Research. 8(3). 356–367. 63 indexed citations
12.
Chauvin, Joë-Marc, Mignane Ka, Ornella Pagliano, et al.. (2020). IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma. Clinical Cancer Research. 26(20). 5520–5533. 114 indexed citations
13.
Moesta, Achim K., Xian-Yang Li, & Mark J. Smyth. (2020). Targeting CD39 in cancer. Nature reviews. Immunology. 20(12). 739–755. 217 indexed citations
14.
O’Donnell, Jake S., Jason Madore, Xian-Yang Li, & Mark J. Smyth. (2019). Tumor intrinsic and extrinsic immune functions of CD155. Seminars in Cancer Biology. 65. 189–196. 102 indexed citations
15.
Chen, Qiuxia, Xue‐Min Cheng, Lifang Zhang, et al.. (2019). Exploring the Lower Limit of Individual DNA-Encoded Library Molecules in Selection. SLAS DISCOVERY. 25(5). 523–529. 20 indexed citations
16.
Yan, Juming, Stacey Allen, Dipti Vijayan, et al.. (2018). Experimental Lung Metastases in Mice Are More Effectively Inhibited by Blockade of IL23R than IL23. Cancer Immunology Research. 6(8). 978–987. 13 indexed citations
17.
Aguilera, Amelia Roman, Viviana P. Lutzky, Deepak Mittal, et al.. (2018). CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity. OncoImmunology. 7(5). e1424677–e1424677. 42 indexed citations
18.
Harjunpää, Heidi, Stephen J. Blake, Elizabeth Ahern, et al.. (2018). Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis. OncoImmunology. 7(7). e1445949–e1445949. 37 indexed citations
19.
Yue, Qing, Xian-Yang Li, Lihong He, et al.. (2016). MiR-124 suppresses the chemotactic migration of rat mesenchymal stem cells toward HGF by downregulating Wnt/β-catenin signaling. European Journal of Cell Biology. 95(9). 342–353. 12 indexed citations
20.
Li, Xian-Yang, Linjia Jiang, Lei Chen, et al.. (2014). RIG-I Modulates Src-Mediated AKT Activation to Restrain Leukemic Stemness. Molecular Cell. 53(3). 407–419. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marika Karikoski Breakdown of academic impact, for papers by Sally A. Hunsucker Breakdown of academic impact, for papers by Joel Crespo Breakdown of academic impact, for papers by Kevin Sek Breakdown of academic impact, for papers by Swetha Anandhan Breakdown of academic impact, for papers by Xuhao Ni Breakdown of academic impact, for papers by Wenzhi Tian Breakdown of academic impact, for papers by Jens Volkmer Breakdown of academic impact, for papers by Junyun Lai Breakdown of academic impact, for papers by Malgorzata Czystowska
Rankless by CCL
2026